Fig. 2From: Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participantsParticipant Enrollment. The final cohort consisted of 20 participants, with 10 (50%, 10/20) receiving genetic counseling, confirmatory genetic testing in a CLIA-laboratory, and consenting to a survey studyBack to article page